Respiratory Diseases Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Respiratory Diseases stocks.

Respiratory Diseases Stocks Recent News

Date Stock Title
May 16 MRK Merck & Co., Inc. (MRK) BofA Securities 2024 Health Care Conference (Transcript)
May 15 MRK Top Stock Reports for Broadcom, Merck & Airbnb
May 15 MRK Merck to Present New Data at 2024 ASCO Annual Meeting Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline
May 14 TBPH Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates
May 14 MRK Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
May 14 MRK Merck cancels trial of melanoma treatment due to immune-mediated adverse events
May 14 AZN PRESS DIGEST-British Business - May 14
May 13 TBPH Theravance Biopharma, Inc. (TBPH) Q1 2024 Earnings Call Transcript
May 13 TBPH Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
May 13 TBPH Theravance Biopharma GAAP EPS of -$0.24 beats by $0.01, revenue of $14.51M beats by $0.56M
May 13 TBPH Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
May 13 AZN UK pharma giants pledge £430m investment in France after Macron charm offensive
May 13 AZN AstraZeneca, Pfizer to invest combined $900M+ in France for R&D, production
May 13 AZN Update: AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study
May 13 MRK Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma Treatment
May 13 AZN Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector
May 13 AZN Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
May 13 AZN France Secures $16 Billion From Microsoft, Amazon and Others at Foreign Investment Summit
May 13 MRK Merck discontinues testing of experimental skin cancer combo therapy
May 13 MRK Merck Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients With Resected High-Risk Melanoma
Respiratory Diseases

Respiratory diseases are a group of conditions that affect the lungs and airways. These diseases can range from mild to severe and can include asthma, COPD, pneumonia, and lung cancer. Symptoms of respiratory diseases can include difficulty breathing, coughing, wheezing, and chest pain. Treatment for respiratory diseases can include medications, lifestyle changes, and surgery.

Browse All Tags